Kessler, C.* et al. Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology. Transl. Oncol. 62:102535 (2025)
Yuan, T.* et al. Identification and external validation of tumor DNA methylation panel for the recurrence risk stratification of stage II colon cancer. Transl. Oncol. 57:102405 (2025)
Jia, J. et al. Improved survival of patients with stage III small-cell lung cancer with primary resection: A SEER-based analysis. Transl. Oncol. 49:102070 (2024)
Salvermoser, L.* et al. CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCC. Transl. Oncol. 43:101919 (2024)
Jia, J. et al. Clinical identification of malignant pleural effusions. Transl. Oncol. 39:101800 (2023)
Menzel, M.* et al. Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD). Transl. Oncol. 35:101706 (2023)
Bauer, V. et al. Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma. Transl. Oncol. 14:101170 (2021)
Balasundaram, G.* et al. Noninvasive anatomical and functional imaging of orthotopic glioblastoma development and therapy using multispectral optoacoustic tomography. Transl. Oncol. 11, 1251-1258 (2018)
Slater, E.P.* et al. MicroRNA-196a and -196b as potential biomarkers for the early detection of familial pancreatic cancer. Transl. Oncol. 7, 464-471 (2014)
Slater, E.P.* et al. LCN2 and TIMP1 as potential serum markers for the early detection of familial pancreatic cancer. Transl. Oncol. 6, 99-103 (2013)
Malinowsky, K.* et al. uPA and PAI-1-related signaling pathways differ between primary breast cancers and lymph node metastases. Transl. Oncol. 5, 98-104 (2012)